|
|
Other links at Articles > HIV/AIDS |
| 1. |
Tenofovir-Based HIV Postexposure Prophylaxis Promising
|
|
|
Use of once-daily tenofovir DF along with lamivudine or emtricitabine may be more effective than previous regimens for non-occupational postexposure prophylaxis (NPEP) in people at high risk for HIV infection, investigators report in the April 1st issue of the Journal of Acquired Immune Deficiency Syndromes. Reuters Health Information
|
| 2. |
Earlier Initiation of Antiretroviral Therapy May Reduce Toxicities
|
|
|
Initiation of antiretroviral therapy at CD4+ counts greater than 200 cells/microliter may reduce the incidence of peripheral neuropathy, anemia, and renal insufficiency, according to a report in the January 1st Journal of Acquired Immune Deficiency Syndromes. Reuters Health Information
|
| 4. |
MI Incidence Stable in Patients on HIV Antiretrovirals
|
|
|
Although the cardiovascular risk profile has worsened in recent years for many patients on long-term combination antiretroviral therapy for HIV infection, there has not been a corresponding increase in myocardial infarctions and other cardiovascular events, researchers report in the April 1st issue of Clinical Infectious Diseases. Reuters Health Information
|
| 5. |
Poly-L-Lactic Acid Injections Provide Modest Aesthetic Benefits in Facial Lipoatrophy
|
|
|
In a study of HIV-infected patients with moderate or severe antiretroviral therapy-induced facial lipoatrophy, injections of poly-L-lactic acid (PLA) produced only modest improvements in objectively assessed facial tissue thickness. However, patients and clinicians perceived significant improvements in facial lipoatrophy severity. Reuters Health Information
|
|
|
